Treatment III: Pharmacologic, Treatment Factors, Outcome Measures

Friday, May 18, 2012: 8:00 AM-12:30 PM
Sheraton Hall (Sheraton Centre Toronto)
9:00 AM
11:00 AM
159 Double-Blind Placebo-Controlled Trial of Methyl B12 Injections for Children with Autism
F. Widjaja, J. E. Choi, S. J. James, R. E. Frye and R. Hendren
10:00 AM
11:00 AM
165 Therapeutic Horseback Riding In Children with Autism Spectrum Disorders
Z. Pan, J. A. Agnew, A. Sholffner, J. Vendl, J. S. Runde and R. L. Gabriels
9:00 AM
10:00 AM
167 A Qualitative Methods Study of How Parents of Children with Autism Find and Use Information about Interventions
S. J. Gentles, K. A. McKibbon, S. Jack, D. B. Nicholas and P. Szatmari
10:00 AM
170 Cerebral Folate Receptor Autoantibodies in Autism Spectrum Disorder
R. E. Frye, J. M. Sequeira, E. V. Quadros, S. J. James and D. Rossignol
11:00 AM
171 Get FRESH: Evaluation of A Healthy Lifestyles Group for Teens with ASDs and Their Parents
S. Nichols, L. Adamek, E. M. Mansdorf, S. P. Tetenbaum, L. B. Perlis and G. Reilly
10:00 AM
173 A Placebo-Controlled, Double-Blinded Study of Minocycline in Children with Fragile X Syndrome
M. J. Leigh, D. Nguyen, T. Winarni, A. Schneider, T. Chechi, S. M. Rivera, D. Hessl and R. J. Hagerman
11:00 AM
174 Societal Economic Burden of Autism on Families in Oman: A Cross-Sectional Study
Y. M. Al-Farsi, M. I. Waly, M. Al-Sharbati, S. Al-Fahdi, A. Al-Farsi, S. Al-Suleimani, O. A. Al-Farsi and M. Al-Shafaee
10:00 AM
176 Treatment of Fragile X Syndrome with STX209 (arbaclofen): Open-Label Extension Experience
R. J. Hagerman, B. Rathmell, P. Wang, M. Cherubini, R. L. Carpenter, M. F. Bear and E. Berry-Kravis
9:00 AM
178 Extended Release Methylphenidate Is Associated with Cognitive Improvement in Children with ASD and Significant ADHD Symptomatology
D. A. Pearson, C. W. Santos, M. G. Aman, L. E. Arnold, C. D. Casat, K. A. Loveland, R. J. Schachar, S. W. Jerger, R. Mansour, D. M. Lane, S. Vanwoerden, E. Ye, P. Narain and L. A. Cleveland
10:00 AM
179 Sex Differences in Co-Occurring Conditions of ASD
M. Stacy, B. Zablotsky, H. Close, B. Makia, A. W. Zimmerman and L. C. Lee
9:00 AM
Measuring Change in Social Competence Observationally in Adults with ASD (Withdrawn)
S. W. White and A. Scarpa
10:00 AM
185 Effects of Ambient Prism Lenses on Autonomic Reactivity to Emotional Stimuli in Autism
G. Sokhadze, M. Kaplan, E. M. Sokhadze, S. M. Edelson, J. M. Baruth, A. S. El-Baz, M. Hensley and M. F. Casanova
11:00 AM
186 Pre-Treatment Gene Expression and Risperidone Associated Weight Gain in Children with Autism Spectrum Disorders (ASD)
J. E. Choi, F. Widjaja, A. D. Sossong, L. Lit, F. R. Sharp and R. Hendren
9:00 AM
187 Metabolic Effects of Tetrahydrobiopterin Treatment
R. E. Frye, R. DeLaTorre, H. Taylor, S. Melnyk and S. J. James
10:00 AM
188 Vocational and Personal Independence Training for Adolescents and Adults with ASD
S. L. Booker, T. Gower Foster, K. Ward and S. V. Leew
11:00 AM
Modulation of RhoGTPases by the Bacterial Protein CNF1 Improves the Neurobehavioural Phenotype in a Mouse Model of Rett Syndrome (Withdrawn)
B. De Filippis, A. Fabbri, D. Simone, R. Canese, F. Malchiodi-Albedi, L. Ricceri, C. Fiorentini and G. Laviola
9:00 AM
193 Behavioral Intervention: Severe Behavior Follow-up Program
A. R. Reavis, N. A. Parks, B. R. Lopez and N. A. Call
10:00 AM
11:00 AM
195 A Structured Indirect Assessment of Problem Behavior Severity
N. A. Parks, D. E. Conine, B. R. Lopez and N. A. Call
11:00 AM
198 Analysis of Demand Assessments in the Treatment of Severe Behavior
J. C. Mintz, N. A. Call and N. A. Parks
9:00 AM
199 Social Validity and the Children with Hyperactivity and Autism Research Treatment Study
J. A. Hollway, P. A. Sayre, M. G. Aman, L. E. Arnold, T. Smith and B. L. Handen
11:00 AM
201 Treatment of Ritualistic Behavior Using Principles of Behavioral Economics
L. A. Pepa, C. Manente, J. Maraventano, A. Shcherbakov, S. Wichtel, I. Jorge, E. Thomas and R. H. LaRue
11:00 AM
204 Development and Interrater Reliability of a New Measure of Functional Behaviour Skills for Children with Autism Spectrum Disorder
B. Lorv, J. A. Reitzel, J. Summers, P. Szatmari, L. Zwaigenbaum, S. Georgiades, E. Duku and M. Gandolfo
9:00 AM
205 The Early Learning Measure As a Predictor for 12- Month Adaptive Behavior Outcomes for Children with Autism and Intellectual Disabilities
J. Summers, J. A. Reitzel, D. Lee, L. Zwaigenbaum, P. Szatmari, S. Georgiades, E. Duku and K. A. Baird
11:00 AM
207 Autism Symptoms and the Functions of Problem Behavior
K. Pelzel, D. P. Wacker, S. D. Lindgren, Y. C. Padilla, J. F. Lee, T. Kopelman, J. Kuhle and D. B. Waldron
9:00 AM
208 Evidence of Frequent Psychotropic Medication Use Among Children with Autism Spectrum Disorders and Their Family Members
A. Jain, D. Spencer, J. Marshall, C. J. Newschaffer, G. Yang, L. J. Lawer and T. Dennen
10:00 AM
209 The EFFECT of A CO-Robot Therapist On Repetitive Behaviors DURING Applied BEHAVIOR ANALYSIS In Individuals with AUTISM Spectrum DISORDERS
E. A. Klinepeter, N. M. Shea, B. Thomas, M. Van Ness, J. Kumar, S. L. Mazur, M. A. Millea, K. Wier, M. Villano, C. R. Crowell and J. J. Diehl
9:00 AM
211 Medication Use Among a Cohort of Adolescents with An Autism Spectrum Disorder
M. Maye, F. Martinez-Pedraza, T. W. Soto, D. K. Anderson, C. E. Lord and L. Wainwright